Advanced Nanofiber Technology in Cancer Management
- 1st Edition - April 1, 2027
- Latest edition
- Editors: Goutam Rath, Goutam Ghosh, Jitu Halder
- Language: English
Advanced Nanofiber Technology in Cancer Management presents a comprehensive exploration of nanofiber-based systems for cancer therapy and diagnostics. It bridges pharma… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Advanced Nanofiber Technology in Cancer Management presents a comprehensive exploration of nanofiber-based systems for cancer therapy and diagnostics. It bridges pharmaceutical sciences, nanotechnology, and oncology to address the challenges of targeted drug delivery and systemic toxicity. The book covers biopolymer, peptide, carbon, and metal nanofibers, detailing their fabrication, characterization, and application in chemotherapy, immunotherapy, gene therapy, and photothermal treatment. It also explores diagnostic innovations such as biosensors and imaging-guided systems, alongside AI and 3D printing in nanofiber development. This volume benefits researchers, clinicians, and pharmaceutical developers by offering translational insights, regulatory perspectives, and real-world case studies. It supports informed decision-making in cancer management and product development.
Key features
Key features
- Provides multidisciplinary coverage of nanofiber applications in cancer therapy, integrating pharmaceutics, nanotechnology, and oncology
- Presents real-world case studies on drug delivery, diagnostics, and resistance mechanisms using advanced nanofiber systems
- Explores translational tools such as AI, 3D printing, and regulatory frameworks to support clinical application and commercialization
Readership
Readership
Researchers in oncology and pharmacology
Table of contents
Table of contents
1. Introduction to nanofiber technology: Early developments
2. Nanofiber technology: State of art and applications
3. Fabrication techniques and characterization of nanofibers
4. Fundamentals of cancer and its management
5. Biopolymers and hybrid nanofibers in cancer management
6. Peptide-based nanofibers in cancer management
7. Carbon-based nanofibers in cancer management
8. Mixed metal and metal oxide nanofibers in cancer management
9. Nanofibers in cancer immunotherapy and gene therapy
10. Nanofibers-assisted photothermal and photodynamic chemotherapy
11. Bio-responsive smart and programmed nanofibers for cancer management
12. Overcoming drug resistance in cancer by nanofiber-based drug delivery
13. Nanofiber-based tissue engineering and cancer management
14. Applications of nanofibers in cancer metastasis inhibition
15. Nanofiber-based biosensors for cancer detection
16. Imaging-guided cancer diagnostics with nanofibers
17. Nanofibers in cancer theranostics
18. Artificial intelligence and 3D printing tools in nanofiber development
19. Regulatory considerations for cancer nanofiber applications
20. Clinical consideration and market potential of nanofibers
21. Current challenges and future prospects
2. Nanofiber technology: State of art and applications
3. Fabrication techniques and characterization of nanofibers
4. Fundamentals of cancer and its management
5. Biopolymers and hybrid nanofibers in cancer management
6. Peptide-based nanofibers in cancer management
7. Carbon-based nanofibers in cancer management
8. Mixed metal and metal oxide nanofibers in cancer management
9. Nanofibers in cancer immunotherapy and gene therapy
10. Nanofibers-assisted photothermal and photodynamic chemotherapy
11. Bio-responsive smart and programmed nanofibers for cancer management
12. Overcoming drug resistance in cancer by nanofiber-based drug delivery
13. Nanofiber-based tissue engineering and cancer management
14. Applications of nanofibers in cancer metastasis inhibition
15. Nanofiber-based biosensors for cancer detection
16. Imaging-guided cancer diagnostics with nanofibers
17. Nanofibers in cancer theranostics
18. Artificial intelligence and 3D printing tools in nanofiber development
19. Regulatory considerations for cancer nanofiber applications
20. Clinical consideration and market potential of nanofibers
21. Current challenges and future prospects
Product details
Product details
- Edition: 1
- Latest edition
- Published: April 1, 2027
- Language: English
About the editors
About the editors
GR
Goutam Rath
Goutam Rath is Professor in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan, Bhubaneswar, India. His research focuses on nanotechnology-based systems for targeted drug and bioactive delivery, with applications in pharmaceutical development and healthcare. Prof. Rath has published extensively in peer-reviewed journals and has contributed to textbooks and book chapters in the fields of pharmaceutics and nanomedicine. His research has resulted in multiple patents, several of which have been transferred for commercial application. He supervises M.Pharm and Ph.D. researchers and serves on national expert panels and advisory groups related to biotechnology, nanomedicine, and pharmaceutical innovation.
Affiliations and expertise
Siksha 'O" Anusandhan, IndiaGG
Goutam Ghosh
Goutam Ghosh is a professor at the School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan , Bhubaneswar, India. With over two decades of academic and research experience, his work focuses on the extraction, separation, and analysis of bioactive compounds from natural sources. His research spans herbal drug discovery and nanotechnology-based delivery systems targeting conditions such as diabetes, arthritis, malaria, cancer, and oxidative stress. He has authored more than 200 publications and has served as Investigator or Co-Principal Investigator on several nationally funded research projects supported by DBT and DST. His contributions to innovative pharmaceutical formulations, including nanofiber-based systems for cancer therapy, have significantly advanced translational medicine.
Affiliations and expertise
Siksha ‘O’ Anusandhan, IndiaJH
Jitu Halder
Dr. Jindu Halder is Assistant Professor in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan, Bhubaneswar, India. His research focuses on the formulation and development of conventional and advanced drug delivery systems, including nanofibers, nanoparticles, and nanogels, with applications in the treatment of infectious diseases and cancer. His work spans pharmaceutical nanotechnology and translational therapeutics, with an emphasis on developing innovative delivery platforms to improve therapeutic outcomes.
Prof. Halder has received research funding from national agencies, including DHR/ICMR, and has contributed to scholarly publications, book chapters, and intellectual property in the field of pharmaceutics. He has been involved in the development of novel drug delivery technologies, including nanofiber-based and mucoadhesive formulations, some of which have progressed toward commercial application through technology transfer initiatives. His academic and research activities continue to support innovation in pharmaceutical sciences and healthcare delivery.
Affiliations and expertise
Siksha ‘O’ Anusandhan, India